Yet Another Public Health Threat: A Commentary and Examination of the Extensive Use of Bromazolam
DOI:
https://doi.org/10.17140/phoj-9-167Keywords:
Bromazolam; Fake Xanax; Opioid misuse; Addiction; Overdose.Abstract
In this commentary, we examine the current state of the science as it pertains to the public health dangers of Bromazolam and its various illicit distribution networks, not only in North America but across the world. We also examine possible directions the substance use disorder (SUD) field may undertake to address the proliferation and abuse of this substance along with overdose prevention efforts that include the public health dangers of Bromazolam use.
References
Papsun DM, Krotulski, AJ, Mastrovito, R, Walton, S, Logan, BK. Bromazolam prevalence surging across the United States driven in part by increasing detections alongside fentanyl. Na-tional Institute of Justice (NIJ) of the U.S. Department of Justice (DOJ). 2022. Website. https://www.cfsre.org/images/content/ reports/public_alerts/Public-Alert_Bromazolam_NPS-Discov-ery_061522.pdf. Accessed December 1, 2023.
Papsun DM, Chan-Hosokawa A, Lamb ME, Logan B. Increas-ing prevalence of designer benzodiazepines in impaired driving: A 5-year analysis from 2017-2021. J Anal Toxicol. 2023; 47(8): 668-679. doi: 10.1093/jat/bkad036
Drug Enforcement Administration, Department of Justice. Schedules of Controlled Substances: Temporary Placement of Eti-zolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclaz-epam in Schedule I. The Federal Register. 2022. Website. https:// www.federalregister.gov/documents/2022/12/23/2022-27278/ schedules-of-controlledsubstances-temporary-placement-of-eti-zolam-flualprazolam-clonazolam. Accessed December 3, 2023.
Mérette SAM, Thériault S, Piramide LEC, Davis MD, Shap-iro AM. Bromazolam blood concentrations in postmortem cas-es—A British Columbia perspective. J Anal Toxicol. 2023; 47(4): 385-392. doi: 10.1093/jat/bkad005
Gatehouse J, Luke M. Deadly drug just ‘a click away,’ warns grieving Ontario family. CBC News. 2023. Website. https:// www.cbc.ca/news/health/bromazolam-online-sales-warn-4 Tiburcio NJ, et al ing-1.6869577. Accessed December 4, 2023.
Blakey K, Thompson A, Matheson A, Griffiths A. What’s in fake ‘Xanax’?: A dosage survey of designer benzodiazepines in counterfeit pharmaceutical tablets. Drug Test Anal. 2022; 14(3): 525-530. doi: 10.1002/dta.3119
Expert Committee on Drug Dependence. Critical review re-port: Bromazolam. World Health Organization (WHO). 2022. Website. https://cdn.who.int/media/docs/default-source/con-trolled-substances/45th-ecdd/bromazolam_draft.pdf ?sfvrsn=f-1bc761e_1. Accessed December 5, 2023.
Government of New Brunswick. Warning about deadly street drug bromazolam. GNB. 2022. Website. https://www2. gnb.ca/content/gnb/en/departments/health/news/news_re-lease.2022.12.0695.html. Accessed December 6, 2023.
Tiburcio NJ, Baker SL. The real deal: A commentary and exam-ination of xylazine use and unintended consequences. Soc Behav Res Pract Open J. 2023; 8(2): 22-24. doi: 10.17140/SBRPOJ-8-140
The White House. FACT SHEET: In continued fight against overdose epidemic, the White House releases national response plan to address the emerging threat of fentanyl combined with xylazine. 2023. Website. https://www.whitehouse.gov/ briefing-room/statements-releases/2023/07/11/fact-sheet-in-continued-fight-against-overdose-epidemic-the-white-house-releases-national-response-plan-to-address-the-emerging-threat-of-fentanyl-combined-with-xylazine/. Accessed December 7, 2023.
Millennium Health. News release: Millennium Health signals alert shows reemergence of deadly carfentanil. 2023. Website. https://www.hmpgloballearningnetwork.com/site/ap/news/ carfentanil-re-emerges-fentanyl-analog-detected-12-states. Ac-cessed December 7, 2023.
Welsh Emerging Drugs and Identification of Novel Substanc-es (WEDINOS). Annual Report. 2022-23. Website. https://www. wedinos.org/resources/downloads/Annual-Report-22-23%20 Welsh.pdf. Accessed December 8, 2023.
European Monitoring Centre for Drugs and Drug Addiction. The misuse of benzodiazepines among high-risk opioid users in Europe (Perspectives on drugs). 2018. Website. https://www. emcdda.europa.eu/publications/pods/benzodiazepines_en. Ac-cessed December 8, 2023.
Orsolini L, Corkery J M, Chiappini S, et al. ‘New/Designer Benzodiazepines’: An analysis of the literature and psychonauts’ trip reports. Curr Neuropharmacol. 2020; 18(9): 809-837. doi: 10.21 74/1570159X18666200110121333
Cooke J. Bromazolam Fact Sheet: Effects, Safety, and Al-ternatives. 2023. Website. https:///tripsitter.com/benzodiaze-pines/bromazalam/. Accessed December 8, 2023.
Homer, I. Chicago Residents Hospitalized After Ingesting Counterfeit Xanax – CDC Issues Bromazolam Warning. Kool 1045fm. 2024. Website. https://kool1045fm.com/chicago-res-idents-hospitalized-after-ingesting-counterfeit-xanax-cdc-is-sues-bromazolam-warning/. Accessed January 8, 2024.
Drug Enforcement Agency. Drugs of Abuse: A DEA Re-source Guide. 2022. Website. https://www.dea.gov/sites/de-fault/files/2022-12/2022_DOA_eBook_File_Final.pdf. Ac-cessed December 11, 2023.
Comms Team. Peterborough Public Health Issues Toxic Drug Submit your article to this journal | https://openventio.org/submit-manuscript/ Commentary | Volume 9 | Number 1 | Tiburcio NJ, et al Alert. Peterborough Public Health. 2023. Website. https://www. peterboroughpublichealth.ca/peterborough-public-health-is-sues-toxic-drug-alert/. Accessed January 8, 2024.
Lazowski LE, Geary BB. Validation of the Adult Substance Abuse Subtle Screening Inventory-4 (SASSI-4). European Journal of Psychological Assessment. 2019; 35(1): 86-97. doi: 10.1027/1015- 5759/a000359
Lazowski LE, Kimmell KS, Baker SL. The Adult Substance Abuse Subtle Screening Inventory-4 (SASSI-4) User Guide & Manual. Springville, IN, USA; The SASSI Institute; 2016.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Public Health - Open Journal (PHOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.